Promise Tracker
0 delivered, 0 close, 3 missed.
View Promises →Godrej Consumer Products reported a mixed Q1 FY25.
✓ Verified against BSE filing
Godrej Consumer Products reported a mixed Q1 FY25. India organic volume growth was 8% on a high base, but revenue growth was muted at 6% due to negative pricing. Indonesia delivered strong constant currency EBITDA growth of 32% on 7% volume growth. GAUM and LATAM saw sharp revenue declines but improved profitability, with GAUM EBITDA margins reaching 14%. Consolidated revenue fell 3% but constant currency revenue grew 9%, and EBITDA grew 13%. Management expects India pricing to turn positive from Q2, targeting low double-digit volume growth for the year. The company announced a foray into pet care with a INR 500 crore investment over five years. Key risks include continued currency volatility in Africa and potential margin pressure from rising palm oil prices.
गोदरेज कंज्यूमर प्रोडक्ट्स ने पहली तिमाही में मिला-जुला प्रदर्शन किया। भारत में बिक्री की मात्रा 8% बढ़ी, लेकिन कम कीमतों के कारण कुल आय सिर्फ 6% बढ़ी। इंडोनेशिया में मुनाफा 32% बढ़ा। अफ्रीका और लैटिन अमेरिका में बिक्री घटी, लेकिन मुनाफा बेहतर हुआ। कंपनी की कुल आय 3% घटी, लेकिन विदेशी मुद्रा में 9% बढ़ी। मुनाफा 13% बढ़ा। कंपनी को उम्मीद है कि भारत में कीमतें अगली तिमाही से बढ़ेंगी और साल भर में बिक्री 10-12% बढ़ेगी। कंपनी पालतू जानवरों के उत्पादों में 500 करोड़ रुपये निवेश करेगी। जोखिम: अफ्रीका में मुद्रा में उतार-चढ़ाव और पाम तेल की बढ़ती कीमतों से मुनाफा कम हो सकता है।
0 delivered, 0 close, 3 missed.
View Promises →Currency volatility in Africa impacting revenue
View Risks →Full transcript text is available on this route.
Read Transcript →India organic volume growth of 8% on a high base of 10% last year.
Indonesia EBITDA grew 32% in constant currency, driven by cost actions and volume growth.
GAUM volumes declined 21% due to currency volatility and distributor destocking.
GCPL to invest INR 500 crore over five years in new pet care subsidiary.
Management expects pricing to become positive sequentially from Q2, with full-year pricing growth of 2-3%.
Management aims for low double-digit volume growth in India for the full year, implying acceleration from 8% in Q1.
Raymond acquisition EBITDA for FY25 is expected to be 15-20% below the original target of INR 160 crore, but significantly higher than the inherited INR 60 crore.
Godrej Pet Care is expected to become cash positive after five years, with manufacturing commencing in H2 FY26.
Management anticipates steady improvement in EBITDA margins through structural cost reduction actions.
Rightful volume growth in household insecticide is about 1.2x GDP, implying 8-9% volume growth.
Air freshener category should grow in high teens to early 20s for some years to come.
Extreme currency fluctuations in Nigeria and Ghana led to distributor destocking and a 21% volume decline in GAUM. High interest rates may prolong the destocking.
Sharp increase in palm oil prices pressured India EBITDA margins in Q1, and management noted it as a headwind for the year.
Integration of urban general trade distribution led to market share loss in deodorants. Management is reverting to a specialized channel, which may delay profit targets.
The INR 500 crore investment in pet care is a long-term bet with uncertain returns. Management acknowledged EBITDA margins may be lower than HPC.
Argentine peso devaluation from 361 to 808 has impacted nine months of revenue, with mid-single-digit negative impact on consolidated sales.
Analyst raised concern that disruptive pricing in liquid detergent could be quickly copied by larger players; management acknowledged but expressed confidence.
Illegal incense sticks offer higher trade margins; management plans to use direct distribution to counter but risk remains.
Mentioned in Q2 FY24, Q3 FY24
Management anticipates steady improvement in EBITDA margins through structural cost reduction actions.
Management expects pricing to become positive sequentially from Q2, with full-year pricing growth of 2-3%.
Extreme currency fluctuations in Nigeria and Ghana led to distributor destocking and a 21% volume decline in GAUM.
View Risks →